Department of Clinical Laboratory, Nagano Municipal Hospital, 1333-1 Tomitake, Nagano, Nagano 381-8551, Japan.
J Infect Chemother. 2012 Dec;18(6):970-2. doi: 10.1007/s10156-012-0424-5. Epub 2012 May 12.
For optimum activity of daptomycin (DAP) in vitro, medium supplemented with calcium ions at physiological concentration (i.e., 50 mg/l) is required for determination of DAP minimum inhibitory concentration (MIC) in the Clinical and Laboratory Standards Institute (CLSI) broth microdilution (BMD) method. However, our literature review found that Mueller-Hinton agar (MHA) brands used for the DAP Etest had different calcium ion (Ca²⁺) concentrations among the reports. For 98 clinical methicillin-resistant Staphylococcus aureus isolates previously unexposed to DAP, MICs were assessed by use of the Etest with MHA plates with different media (MHA-A, MHA-B, and MHA-C) and compared with those from the CLSI reference BMD method. The instructions for the Etest recommend MHA with Ca²⁺ of 25-40 mg/l for DAP MIC testing; Ca²⁺ concentrations for each type of MHA were 20.4 mg/l in MHA-A, 45.2 mg/l in MHA-B, and 52.0 mg/l in MHA-C. When the MIC₅₀/MIC₉₀ of the clinical isolates were studied, the Etest MICs for MHA-A were 1-fold dilution higher than for the BMD value. In contrast, for MHA-B they were 1-fold dilution lower, and for MHA-C MIC₅₀ was 1.5-fold dilution lower and MIC₉₀ was 2-fold dilution lower. MICs measured in MHA with higher Ca²⁺ tended to be lower. Comparison of MICs between BMD and the Etest for each MHA showed they were significantly different (p < 0.0001). The correlation coefficient was 0.6258 (p < 0.0001) for MHA-A, 0.4224 (p < 0.0001) for MHA-B, and 0.2504 (p = 0.0129) for MHA-C. Our results suggest there are differences in DAP MICs between MIC testing methods and differences between Ca²⁺ concentrations in MHA. For more objective and accurate measurement of DAP MICs, there should be discussion about standardization of Ca²⁺ in MHA.
为了使达托霉素(DAP)在体外达到最佳活性,在临床和实验室标准协会(CLSI)肉汤微量稀释(BMD)方法中测定 DAP 最低抑菌浓度(MIC)时,需要使用生理浓度(即 50mg/L)的钙离子补充培养基。然而,我们的文献综述发现,用于 DAP Etest 的 Mueller-Hinton 琼脂(MHA)品牌在报告中的钙离子(Ca²⁺)浓度不同。对于 98 株以前未接触过 DAP 的耐甲氧西林金黄色葡萄球菌临床分离株,使用不同培养基(MHA-A、MHA-B 和 MHA-C)的 Etest 评估 MIC,并与 CLSI 参考 BMD 方法的 MIC 进行比较。Etest 的说明书建议使用 Ca²⁺浓度为 25-40mg/L 的 MHA 进行 DAP MIC 检测;MHA-A 中的 Ca²⁺浓度为 20.4mg/L,MHA-B 中的 Ca²⁺浓度为 45.2mg/L,MHA-C 中的 Ca²⁺浓度为 52.0mg/L。当研究临床分离株的 MIC₅₀/MIC₉₀时,Etest 对 MHA-A 的 MIC 比 BMD 值高 1 倍稀释。相比之下,对于 MHA-B,MIC 低 1 倍稀释,对于 MHA-C,MIC₅₀ 低 1.5 倍稀释,MIC₉₀ 低 2 倍稀释。Ca²⁺浓度较高的 MHA 测量的 MIC 往往较低。比较 BMD 和每种 MHA 的 Etest 之间的 MIC,结果显示它们有显著差异(p<0.0001)。MHA-A 的相关系数为 0.6258(p<0.0001),MHA-B 的相关系数为 0.4224(p<0.0001),MHA-C 的相关系数为 0.2504(p=0.0129)。我们的结果表明,DAP MIC 检测方法之间存在差异,MHA 中的 Ca²⁺浓度也存在差异。为了更客观、准确地测量 DAP MIC,应讨论 MHA 中 Ca²⁺的标准化问题。